Weekly update Companies AI-cruiter Recruiting

QurAlis

QurAlis

Founded: 2016

Location: Cambridge, MA

Employee range: 11 - 50

Clinical stage: Clin1

Therapy area: ALS

Drug types: NEU

Lead product: QRL-201

Product link: https://quralis.com/pipeline/

Funding: $88M B Mar 2023; $42M May 2020; $5.5M Seed Nov 2018

Investors: EQT Life Sciences, Droia Ventures, Sanofi Ventures, BioInnovation Capital, Viva Biotech Limited, Alexandria, Amgen, MP Healthcare Venture Management, ALS Investment Fund, LS Polaris Innovation Fund, Mission BioCapital, INKEF Capital, Dementia Discovery Fund, Amgen Ventures, MP Healthcare Venture Management, Mitsui Global Investment, Dolby Family Ventures, Mission Bay Capital, Sanford Biosciences

Short description:

ALS cure - Small Molecules, ASO

Drug notes:

QRL-201/QRL-203 Clin0 FTD, Clin0 PLS; QRL-101 Clin1 ALS, Clin0 FTD; QRL-204 Clin0 ALS/FTD, Clin0 FTD

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:

Director of Drug Substance Manufacturing

Cambridge, MA|9 days ago

Director, Clinical Supply Chain

Cambridge, MA|50 days ago

Main

© 2024 Work In Biotech LLC

Terms of Service

Contact: recruit@workinbiotech.com